Kidney Failure News and Research

RSS

Study: Brain connectivity network in T1D patients is different from healthy people

Patients with Type 1 Diabetes have a brain connectivity network different from the healthy people, according to a new study led by researchers of the Institute of Neurosciences and the Institute of Complex Systems of the University of Barcelona.

19 Dec 2018

Kidney failure is increasing in Australians under 50 with type 2 diabetes, study finds

A study of more than 1.3 million Australians with diabetes has found that kidney failure is increasing in people with type 2 diabetes aged under 50 years, leading to reduced quality of life and placing growing demand on the country's kidney dialysis and transplantation services.

19 Dec 2018

Statins associated with low risk of side effects

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients.

10 Dec 2018

Men with CKD more likely to experience disease progression and death than women

Researchers at the University of Illinois at Chicago have found that men with chronic kidney disease, or CKD, are more likely to experience disease progression and death when compared with women suffering from the same condition.

5 Dec 2018

Research reveals how a small molecule helps remove excess cholesterol

Scientists have determined the structure of the activated form of an enzyme that helps to return excess cholesterol to the liver, a study in eLife reports.

27 Nov 2018

Myriad biological, societal factors that impact CKD severity for children of African descent

Myriad biological and societal factors can impact the occurrence and accelerate progression of chronic kidney disease for children of African descent - including preterm birth, exposure to toxins during gestation and lower socioeconomic status - and can complicate these children's access to effective treatments, according to an invited commentary published in the November 2018 edition of American Journal of Kidney Diseases.

21 Nov 2018

Gene editing could be used to halt kidney disease in patients with Joubert syndrome

For the first time scientists have identified how to halt kidney disease in a life-limiting genetic condition, which may pave the way for personalized treatment in the future.

16 Nov 2018

Brain and muscle cells found within kidney organoids

Researchers have discovered the presence of rogue brain and muscle cells inside kidney organoids and used artificial intelligence to remove them.

15 Nov 2018

Parents and carers of people with diabetes experience emotional or mental health problems

Research from Diabetes UK has found that – alongside those living with the condition – parents and carers of children and adults with diabetes experience emotional or mental health problems.

15 Nov 2018

Expert suggests ways to control uncomfortable vaginal symptoms in diabetic women

With approximately 9.7 million women in the U.S. suffering with diabetes and almost 50 million U.S. adults with prediabetes, most of the women are experiencing uncomfortable vaginal symptoms like recurrent yeast and bacterial infections, vaginal dryness, reduced sexual interest, and painful intercourse that can adversely affect quality of life.

15 Nov 2018

EU and industry-funded project aims to personalize diabetes treatment

Diabetes is a chronic and incurable illness linked to blood sugar that has traditionally been divided into type 1 and type 2. Type 2 accounts for the vast majority of cases – some 285 million – and its prevalence is expected to soar over the coming decade.

14 Nov 2018

Newly designed mice emulate severe form of kidney damage in humans with diabetes

Scientists led by Duke-NUS Medical School have designed mice that successfully emulate a severe form of kidney damage in humans with diabetes, called diabetic nephropathy.

9 Nov 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

Cryo-electron microscopy helps study proteins responsible for amyloid-based diseases

The century old mission to understand how the proteins responsible for amyloid-based diseases such as Alzheimer's, Huntingdon's and Parkinson's work has taken major steps forward in the last 12 months, thanks to a revolution in a powerful microscopy technique used by scientists.

30 Oct 2018

Dialysis giant Davita defends itself in court and at the polls

It's been a year of playing defense for DaVita Inc., one of the country's largest dialysis providers.

29 Oct 2018

High-impact clinical trial results could affect kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at the San Diego Convention Center.

26 Oct 2018

High-dose influenza vaccine associated fewer hospitalizations in dialysis patients

Results from a new study suggest that high-dose influenza vaccine is associated with lower risk for hospitalizations in kidney failure patients on dialysis. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology

24 Oct 2018

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

23 Oct 2018

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.

22 Oct 2018

Not exercising is worse than smoking, diabetes or heart disease finds study

The study was published in the latest issue of the JAMA Network Open journal. For this the researchers followed up health, exercise and lifestyle data of 122,007 participants over 23 years to reach these conclusions.

21 Oct 2018

Kidney Failure News and Research

Study: Brain connectivity network in T1D patients is different from healthy people

Kidney failure is increasing in Australians under 50 with type 2 diabetes, study finds

Statins associated with low risk of side effects

Men with CKD more likely to experience disease progression and death than women

Research reveals how a small molecule helps remove excess cholesterol

Myriad biological, societal factors that impact CKD severity for children of African descent

Gene editing could be used to halt kidney disease in patients with Joubert syndrome

Brain and muscle cells found within kidney organoids

Parents and carers of people with diabetes experience emotional or mental health problems

Expert suggests ways to control uncomfortable vaginal symptoms in diabetic women

EU and industry-funded project aims to personalize diabetes treatment

Newly designed mice emulate severe form of kidney damage in humans with diabetes

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Cryo-electron microscopy helps study proteins responsible for amyloid-based diseases

Dialysis giant Davita defends itself in court and at the polls

High-impact clinical trial results could affect kidney-related medical care

High-dose influenza vaccine associated fewer hospitalizations in dialysis patients

Lowering systolic blood pressure does not damage the kidneys, shows study

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Not exercising is worse than smoking, diabetes or heart disease finds study

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News